Abstract
The problem of the combination of ankylosing spondylitis (AS) and inflammatory bowel diseases (IBD) is interdisciplinary. Modern approaches to studying this issue among rheumatologists and gastroenterologists are somewhat different. The combination of these two pathologies is a potential factor for a more severe course of these diseases. The article provides an overview of some markers that have shown high specificity in the diagnosis of AS and IBD
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
